Skip to main content

Advertisement

Log in

Vindesine a short review of preclinical and first clinical data

  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

VCR:

vincristine

VBL:

vinblastine

VDS:

vindesine, desacetylvinblastine amide sulfate

CR:

complete response

PR:

partial response

MR:

minimal response

References

  1. Barnett, C. J., Cullinan, G. J., Gerzon, K., Hoying, R. C., Jones, W. E., Newlon, W. M., Poore, G. A., Robinson, R. L., Sweeney, M. J., Todd, G. C.: Structure-activity relationships of dimeric catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate. J. Med. Chem. 21, 88 (1978)

    Google Scholar 

  2. Bensch, K. G., Malawista, S. E.: Microtubule crystals in mammalina cells. J. Cell Biol. 40, 95 (1969)

    Google Scholar 

  3. Blum, R. H., Dawson, D. M.: Vindesine (V) — Phase I study of vinca alkaloid. Proc. Am. Assoc. Cancer Res./Am. Soc. Clin. Oncol. 17, 108 (1976)

    Google Scholar 

  4. Bodey, G. P., Freireich, E. J.: Initial clinical studies of vindesine (desacetyl vinblastine amide sulfate). Proc. Am. Assoc. Cancer Res./Am. Soc. Clin. Oncol. 17, 128 (1976)

    Google Scholar 

  5. Bodey, G. P., Lagakos, S. W., Guitierrez, A. C., et al.: Therapy of advanced squamous carcinoma of the lung: cyclophosphamide versus “COMB”. Cancer 39, 1026–1031 (1977)

    Google Scholar 

  6. Casey, E. B., Jellife, A. M., Lequesne, P. M., Millett, Y. L.: Vincristine neuropathy: Clinical and electrophysiological observations. Brain 96, 69 (1973)

    CAS  PubMed  Google Scholar 

  7. Culp, H. W., Daniels, W. D., McMahon, R. E.: Disposition and tissue levels of (3H) vindesine in rats. Cancer Res. 37, 3053 (1977)

    Google Scholar 

  8. Dentler, W. L., Granett, S., Rosenbaum, J. L.: Ultrastructural localization of the high molecular weight proteins associated with in vitro-assembled brain microtubules. J. Cell Biol. 65, 237 (1975)

    Google Scholar 

  9. Dyke, R. W.: Present status of vindesine safety and efficacy data. In: Proceedings of the International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) 1979

    Google Scholar 

  10. Dyke, R. W., Nelson, R. L.: Phase I anti-cancer agents. Vindesine (desacetyl vinblastine amide sulfate). Cancer Treat. Rev. 4, 135 (1977)

    Google Scholar 

  11. Dyke, R. W., Nelson, R. L.: Phase I–II clinical investigation of vindesine (desacetyl vinblastine amide sulfate, DVA). Curr. Chemother. 2, (Abstract 640) (1978)

    Google Scholar 

  12. Einhorn, L. H., Furnas, B.: Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU. Cancer Treat. Rep. 61, 881–883 (1977)

    Google Scholar 

  13. Gralla, R. J., Tan, C. T. C., Young, C. W.: Review of Phase-II Studies of vindesine at the Memorial Sloan-Kettering Cancer Center. In: Proceedings of the First International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)

    Google Scholar 

  14. Hargrove, W. W.: Preparation and activities of chemically modified dimeri catharanthus alkaloids. Lloydia 27, 340 (1964)

    Google Scholar 

  15. Himes, R. H., Kersey, R. N., Heller-Bettinger, I., Samson, F. E.: Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide in microtubules in vitro. Cancer Res. 36, 3798 (1976)

    Google Scholar 

  16. Holland, J. F., Adrejczuk, A., Grenspan, E.: Initial clinical and pharmacological studies with vindesine: i. v. bolus versus 24-hrs infusion. Proc. Am. Assoc. Cancer Res. 129 (Abstract) (1978)

  17. Korolkovas, A.: Grundlagen der molekularen Pharmakologie. (Essentials of Molecular Pharmacology). p. 80. Stuttgart: Thieme/Frankfurt: Wiley (1974)

    Google Scholar 

  18. Krivit, W., Hammond, D.: Vindesine: a phase II study by the Childrens Cancer Study Group. Curr. Chemother. 2, 1331 (1978)

    Google Scholar 

  19. Krivit, W., Chilcote, R., Kyesmany, A., Sather, H., Anderson, J., Hammond, D.: Vindesine — Phase III. In: Proceedings of the First International Workshop on Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)

    Google Scholar 

  20. Loeb, E., Hill, J. M., Pardue, A. S., Khan, A., Hill, N. O., King, J. J., Hill, R.: Vindesine, a new vinca alkaloid in the treatment of leukemias and lymphomas. Curr. Chemother. 2, 1334 (1978)

    Google Scholar 

  21. Mathé, G.: Experiences with vindesine at Villejuif. In: Proceedings of the First International Workshop on Vindesine, July 7, 1978 Stuttgart: Thieme (in press) (1979)

    Google Scholar 

  22. Mathé, G., Misset, J. L., De Vassal, F., Hayat, M., Machover, D., Bel Pomme, D., Schwarzenberg, L., Ribaud, P., Musset, H., Jasmin, C.: Phase-II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of myeloid leukemia, lymphosarcoma, and Hodgkin's disease. Absence of cross-resistance with vincristine. Med. Oncol. 3, S21 (Abstract 51) (1977)

  23. Mathé, G., Misset, J. L., De Vassal, F., Hayat, M., Machover, D., Bel Pomme, D., Schwarzenberg, L., Ribaud, P., Musset, M., Jasmin, C.: Phase-II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and Hodgkin's disease. Absence of cross-resistance with vincristine. Cancer Treat. Rep. 62, 805 (1978)

    Google Scholar 

  24. Nelson, R. L., Dyke, R. W.: Phase I–II clinical investigation of vindesine (desacetyl vinblastine amide sulfate). Curr. Chemother. 2, 1328 (1978)

    Google Scholar 

  25. Nelson, R. L., Root, M. A., Dyke, R. W., Ahmadzai, S.: Pharmacokinetics of desacetyl vinblastine amide (vindesine) in man. Proc. Am. Assoc. Cancer Res. 17, 30 (1976)

    Google Scholar 

  26. Obrist, R., Paravicini, U., Hartmann, D., Nagel, G., Obrecht, J. P.: Vindesine — A clinical trial with special reference to neurological side effects. In: Proceedings of the International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)

    Google Scholar 

  27. Ochs, S., Worth, R.: Comparison of the block of fast axoplasmic transport in mammalian nerve by vincristine, vinblastine and desacetyl vinblastine amide sulfate (DVA) Am. Assoc. Cancer Res. 16, (Abstracts no. 278 and 70) (1975)

  28. Olmsted, J. B., Borisy, G. G.: Microtubules. Ann. Rev. Biochem. 42, 507 (1973)

    Google Scholar 

  29. Owellen, R. J.: The pharmacokinetics of aromatic ring 3H-vinblastine in humans. Fed. Proc. 34, 808 (1975)

    Google Scholar 

  30. Owellen, R. J., Donigian, D. W., Hartke, C. A., Dickerson, R. M., Kuhar, M. J.: The binding of vinblastine to tubulin and to particulate fractions of mammalian brain. Cancer Res. 34, 3180 (1974)

    Google Scholar 

  31. Owellen, R. J., Hartke, C. A., Dickerson, R. M., Hains, F. O.: Inhibition of tubulin-microtubule polymerization by drugs of the vinca alkaloid class. Cancer Res. 36, 1499 (1976)

    Google Scholar 

  32. Powles, T., Smith, I.: Vindesine in the treatment of breast cancer. In: Proceedings of the First International Workshop of Vindesine, July 7, 1978. Stuttgart: Thieme (in press) (1979)

    Google Scholar 

  33. Retsas, S., Newton, K. A., Westbury, G.: Vindesine as a single agent in the treatment of advanced malignant melanoma. In: Proceedings of the First International Workshop of Vindesine, July 7, 1978 Stuttgart: Thieme (in press) (1979)

    Google Scholar 

  34. Root, M. A., Gerzon, K., Dyke, R. W.: A radioimmunoassay for vinblastine and vincristine. Federation of Analytical Chemistry and Spectroscopy Societies, p. 125, Indianapolis, Indiana (1975)

    Google Scholar 

  35. Rosenthal, S., Kaufman, S.: Vincristine neurotoxicity. Ann. Intern. Med. 80, 733 (1974)

    Google Scholar 

  36. Smith, I. E., Hedley, D. W., Powles, T. J., McElwain, T. J.: Vindesine in the treatment of breast carcinoma, malignant melanoma and other solid tumors. Paper presented at the Sixth Vinca alkaloid symposion, London, October 20, 1978

  37. Soifer, D. (ed): New York Academy of Science Conference on the Biology of Cytoplasmic Microtubules. Ann. NY Acad. Sci. 253, 1 (1975)

  38. Sweeney, M. J., Cullinan, G. J., Poore, G. A., Gerzon, K.: Experimental antitumor activity of vinblastine amides. Proc. Am. Assoc. Cancer Res. 15, 37 (1974)

    Google Scholar 

  39. Tan, C.: Clinical and pharmacokinetic studies of vindesine in 50 children with malignant diseases. Curr. Chemother. 2, 1326 (1978)

    Google Scholar 

  40. Todd, G. C., Gibson, W. R., Griffing, W. J., Morton, D. M.: The preclinical study of desacetyl vinblastine amide. Proc. Am. Assoc. Cancer Res. 16, 70 (1975)

    Google Scholar 

  41. Todd, G. C., Gibson, W. R., Morton, D. M.: Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs. J. Toxicol. Environ. Health 1, 843 (1976)

    Google Scholar 

  42. Weiss, H. D., Walker, M. D., Wiernik, P. H.: Neurotoxicity of commonly used antineoplastic agents. N. Engl. J. Med. 291, 75 (1974)

    Google Scholar 

  43. Wilson, L.: Microtubules as drug receptors: Pharmacological properties of microtubules protein. Ann. NY Acad. Sci. 253, 213 (1975)

    Google Scholar 

  44. Young, Ch.: Phase II evaluation of vindesine in patients with advanced cancer. Paper presented at the Sixth Vinca Alkaloid Symposium, London, October 20, 1978

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dyke, R.W., Nelson, R.L. & Brade, W.P. Vindesine a short review of preclinical and first clinical data. Cancer Chemother. Pharmacol. 2, 229–232 (1979). https://doi.org/10.1007/BF00257185

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00257185

Keywords

Navigation